STAT3 or USF2 Contributes to HIF Target Gene Specificity

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Pawlus, Matthew R ^a   Wang, Liyi ^a   Murakami, Aya ^a   Dai, Guanhai ^b   Hu, Cheng Jun ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Center for Experimental Animals   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2; HYPOXIA INDUCIBLE FACTOR 2ALPHA; RNA POLYMERASE II; STAT3 PROTEIN; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 2;

ARTICLE; CA9 GENE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPO GENE; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PAI1 GENE; PGK1 GENE; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REPORTER GENE;

ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CELL LINE; GENES, REPORTER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA POLYMERASE II; STAT3 TRANSCRIPTION FACTOR; UPSTREAM STIMULATORY FACTORS;

EID: 84882668941     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072358     Document Type: Article

References (49)

1. Wang GL, Jiang BH, Rue EA, Semenza GL, (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92: 5510-5514. doi:10.1073/pnas.92.12.5510. PubMed: 7539918.
2. Wang GL, Semenza GL, (1995) Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230-1237. doi:10.1074/jbc.270.3.1230. PubMed: 7836384.
3. Semenza GL, (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148: 399-408. doi:10.1016/j.cell.2012.01.021. PubMed: 22304911.
4. Keith B, Johnson RS, Simon MC, (2012) HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 12: 9-22.
5. Kaelin WG Jr., (2011) Cancer and Altered Metabolism: Potential Importance of Hypoxia-Inducible Factor and 2-Oxoglutarate-Dependent Dioxygenases. Cold Spring Harb Symp Quant Biol, 76: 335-45. PubMed: 22089927.
6. Finger EC, Giaccia AJ, (2010) Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev 29: 285-293. doi:10.1007/s10555-010-9224-5. PubMed: 20393783.
7. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ, (1997) Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. J Biol Chem 272: 11205-11214. doi:10.1074/jbc.272.17.11205. PubMed: 9111021.
8. Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW, (1998) Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201: 1153-1162. PubMed: 9510527.
9. O'Rourke JF, Tian YM, Ratcliffe PJ, Pugh CW, (1999) Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1alpha. J Biol Chem 274: 2060-2071. doi:10.1074/jbc.274.4.2060. PubMed: 9890965.
10. Semenza GL, Agani F, Booth G, Forsythe J, Iyer N, et al. (1997) Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int 51: 553-555. doi:10.1038/ki.1997.77. PubMed: 9027737.
11. Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL, (1997) Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem 272: 19253-19260. doi:10.1074/jbc.272.31.19253. PubMed: 9235919.
12. Hu CJ, Sataur A, Wang L, Chen H, Simon MC, (2007) The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell 18: 4528-4542. doi:10.1091/mbc.E06-05-0419. PubMed: 17804822.
13. Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U, et al. (2004) Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J 18: 1462-1464. PubMed: 15240563.
14. Hu CJ, Iyer S, Sataur A, Covello KL, Chodosh LA, et al. (2006) Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells. Mol Cell Biol 26: 3514-3526. doi:10.1128/MCB.26.9.3514-3526.2006. PubMed: 16611993.
15. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC, (2003) Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23: 9361-9374. doi:10.1128/MCB.23.24.9361-9374.2003. PubMed: 14645546.
16. Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, et al. (2007) Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci U S A 104: 2301-2306. doi:10.1073/pnas.0608382104. PubMed: 17284606.
17. Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, et al. (2007) Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117: 1068-1077. doi:10.1172/JCI30117. PubMed: 17404621.
18. Rankin EB, Rha J, Selak MA, Unger TL, Keith B, et al. (2009) Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol 29: 4527-4538. doi:10.1128/MCB.00200-09. PubMed: 19528226.
19. Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, et al. (2005) Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 25: 5675-5686. doi:10.1128/MCB.25.13.5675-5686.2005. PubMed: 15964822.
20. Mastrogiannaki M, Matak P, Keith B, Simon MC, Vaulont S, et al. (2009) HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest 119: 1159-1166. doi:10.1172/JCI38499. PubMed: 19352007.
21. Wang V, Davis DA, Haque M, Huang LE, Yarchoan R, (2005) Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res 65: 3299-3306. PubMed: 15833863.
22. Lau KW, Tian YM, Raval RR, Ratcliffe PJ, Pugh CW, (2007) Target gene selectivity of hypoxia-inducible factor-alpha in renal cancer cells is conveyed by post-DNA-binding mechanisms. Br J Cancer 96: 1284-1292. doi:10.1038/sj.bjc.6603675. PubMed: 17387348.
23. Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, et al. (2009) Genome-wide association of hypoxia-inducible factor (HIF)-1{alpha} and HIF-2{alpha} DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem 284: 16767-16775. doi:10.1074/jbc.M901790200. PubMed: 19386601.
24. Schödel J, Oikonomopoulos S, Ragoussis J, Pugh CW, Ratcliffe PJ, et al. (2011) High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117: e207-e217. doi:10.1182/blood-2010-10-314427. PubMed: 21447827.
25. Thanos D, Maniatis T, (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100. doi:10.1016/0092-8674(95)90136-1. PubMed: 8548797.
26. Elvert G, Kappel A, Heidenreich R, Englmeier U, Lanz S, et al. (2003) Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 278: 7520-7530. doi:10.1074/jbc.M211298200. PubMed: 12464608.
27. Greijer AE, van der Groep P, Kemming D, Shvarts A, Semenza GL, et al. (2005) Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206: 291-304. doi:10.1002/path.1778. PubMed: 15906272.
28. Pawlus MR, Wang L, Hu CJ, (2013) STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells. Oncogene: in press.
29. Pawlus MR, Wang L, Ware K, Hu CJ, (2012) Upstream stimulatory factor 2 and hypoxia-inducible factor 2alpha (HIF2alpha) cooperatively activate HIF2 target genes during hypoxia. Mol Cell Biol 32: 4595-4610. doi:10.1128/MCB.00724-12. PubMed: 22966206.
30. Levy DE, Inghirami G, (2006) STAT3: a multifaceted oncogene. Proc Natl Acad Sci U S A 103: 10151-10152. doi:10.1073/pnas.0604042103. PubMed: 16801534.
31. Corre S, Galibert MD, (2005) Upstream stimulating factors: highly versatile stress-responsive transcription factors. Pigment Cell Res 18: 337-348. doi:10.1111/j.1600-0749.2005.00262.x. PubMed: 16162174.
32. Grabmaier K, Adw MC, Verhaegh GW, Schalken JA, Oosterwijk E, (2004) Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma. Oncogene 23: 5624-5631. doi:10.1038/sj.onc.1207764. PubMed: 15184875.
33. Maxwell P, Ratcliffe P, (1998) Regulation of expression of the erythropoietin gene. Curr Opin Hematol 5: 166-170. doi:10.1097/00062752-199805000-00003. PubMed: 9664154.
34. Hu J, Stiehl DP, Setzer C, Wichmann D, Shinde DA, et al. (2011) Interaction of HIF and USF signaling pathways in human genes flanked by hypoxia-response elements and E-box palindromes. Mol Cancer Res 9: 1520-1536. doi:10.1158/1541-7786.MCR-11-0090. PubMed: 21984181.
35. Jung JE, Lee HG, Cho IH, Chung DH, Yoon SH, et al. (2005). STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. Faseb J 19: 1296-1298.
36. Pawlus MR, Wang L, Hu CJ, (2013). STAT3 and HIF1alpha cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells. Oncogene.
37. Jung JE, Kim HS, Lee CS, Shin YJ, Kim YN, et al. (2008). STAT3 inhibits the degradation of HIF-1alpha by pVHL-mediated ubiquitination. Exp Mol Med 40: 479-485.
38. Dimova EY, Kietzmann T, (2006) Cell type-dependent regulation of the hypoxia-responsive plasminogen activator inhibitor-1 gene by upstream stimulatory factor-2. J Biol Chem 281: 2999-3005. PubMed: 16330554.
39. Alfranca A, Gutiérrez MD, Vara A, Aragonés J, Vidal F, et al. (2002) c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol Cell Biol 22: 12-22. doi:10.1128/MCB.22.1.12-22.2002. PubMed: 11739718.
40. Aprelikova O, Wood M, Tackett S, Chandramouli GV, Barrett JC, (2006) Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res 66: 5641-5647. doi:10.1158/0008-5472.CAN-05-3345. PubMed: 16740701.
41. Emerling BM, Weinberg F, Liu JL, Mak TW, Chandel NS, (2008) PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). Proc Natl Acad Sci U S A 105: 2622-2627. doi:10.1073/pnas.0706790105. PubMed: 18268343.
42. Figueroa YG, Chan AK, Ibrahim R, Tang Y, Burow ME, et al. (2002) NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. Exp Hematol 30: 1419-1427. doi:10.1016/S0301-472X(02)00934-7. PubMed: 12482504.
43. Hu J, Stiehl DP, Setzer C, Wichmann D, Shinde DA, et al. (2011) Interaction of HIF and USF Signaling Pathways in Human Genes Flanked by Hypoxia-Response Elements and E-box Palindromes. Mol Cancer Res 9: 1520-1536. doi:10.1158/1541-7786.MCR-11-0090. PubMed: 21984181.
44. Rankin EB, Rha J, Unger TL, Wu CH, Shutt HP, et al. (2008) Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 27: 5354-5358. doi:10.1038/onc.2008.160. PubMed: 18490920.
45. Kondo K, Kim WY, Lechpammer M, Kaelin WG Jr., (2003) Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. PLOS Biol 1: E83. PubMed: 14691554.
46. Kim WY, Safran M, Buckley MR, Ebert BL, Glickman J, et al. (2006) Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo. EMBO J 25: 4650-4662. doi:10.1038/sj.emboj.7601300. PubMed: 16977322.
47. Mazumdar J, Hickey MM, Pant DK, Durham AC, Sweet-Cordero A, et al. (2010) HIF-2alpha deletion promotes Kras-driven lung tumor development. Proc Natl Acad Sci U S A 107: 14182-14187. doi:10.1073/pnas.1001296107. PubMed: 20660313.
48. Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC, (2007) HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11: 335-347. doi:10.1016/j.ccr.2007.02.006. PubMed: 17418410.
49. Imamura T, Kikuchi H, Herraiz MT, Park DY, Mizukami Y, et al. (2009) HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int J Cancer 124: 763-771. doi:10.1002/ijc.24032. PubMed: 19030186.